Fig. 5From: Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significanceTwo nomograms and corresponding results showed the prognostic value of AS events and clinicopathologic data. Nomogram for predicting OS (a) and DFS (d) in the HP− GC cohort. Calibration plot of the AS-clinicopathologic nomogram in terms of the agreement between nomogram-predicted and observed 1-, 2-, and 3-years OS (b) and DFS (e) in the HP− GC cohort. c, f Decision curve analysis of the AS-clinicopathologic nomogram for 1-, 2-, and 3-years risk in the HP− GC cohort. AS alternative splicing, OS overall survival, DFS disease-free survival, HP−GC Helicobacter pylori-negative gastric cancer, ROC receiver operating characteristicBack to article page